Thu, March 7, 2013
Wed, March 6, 2013
[ Wed, Mar 06th 2013 ] - Market Wire
Alchemia Granted Key US Patent
Tue, March 5, 2013
Mon, March 4, 2013
Sun, March 3, 2013
Sat, March 2, 2013
Fri, March 1, 2013
Thu, February 28, 2013
Wed, February 27, 2013
Tue, February 26, 2013
Mon, February 25, 2013
Sun, February 24, 2013
Sat, February 23, 2013
Fri, February 22, 2013
Thu, February 21, 2013
[ Thu, Feb 21st 2013 ] - Market Wire
Inorganic Growth of Healthcare
Wed, February 20, 2013
Tue, February 19, 2013
Mon, February 18, 2013
Sun, February 17, 2013
Fri, February 15, 2013
Thu, February 14, 2013
Wed, February 13, 2013
Tue, February 12, 2013

PDL BioPharma to Announce Fourth Quarter and Full Year 2012 Financial Results on March 1, 2013


//health-fitness.news-articles.net/content/2013/ .. year-2012-financial-results-on-march-1-2013.html
Published in Health and Fitness on by Market Wire   Print publication without navigation


PDL BioPharma to Announce Fourth Quarter and Full Year 2012 Financial... -- INCLINE VILLAGE, Nev., Feb. 25, 2013 /PRNewswire/ --

INCLINE VILLAGE, Nev., Feb. 25, 2013 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: [ PDLI ]) today announced that the Company will release its fourth quarter and full year 2012 financial results for the period ended December 31, 2012, on Friday, March 1, 2013, after market close. PDL's management will host a conference call and webcast that day at 4:30 p.m. Eastern Time to discuss the financial results.  A slide presentation relating to the call will be available via the webcast link on the PDL website.

(Logo:  [ http://photos.prnewswire.com/prnh/20110822/SF55808LOGO ])

Conference Call Details
To access the live conference call via phone, please dial (800) 668-4132 from the United States and Canada or (224) 357-2196 internationally. The conference ID is 12523654. Please dial in approximately 10 minutes prior to the start of the call. A telephone replay will be available beginning approximately one hour after the call through March 8, 2013, and may be accessed by dialing (855) 859-2056 from the United States and Canada or (404) 537-3406 internationally. The replay passcode is 12523654.

To access the live and subsequently archived webcast of the conference call, go to the Company's website at [ http://www.pdl.com ] and go to "Company Presentations & Events." Please connect to the website at least 15 minutes prior to the call to allow for any software download that may be necessary.

About PDL BioPharma
PDL pioneered the humanization of monoclonal antibodies and, by doing so, enabled the discovery of a new generation of targeted treatments for cancer and immunologic diseases. Today, PDL is focused on intellectual property asset management, investing in new income generating assets and maximizing value for its shareholders. For more information, please visit [ www.pdl.com ].

NOTE: PDL BioPharma and the PDL BioPharma logo are considered trademarks of PDL BioPharma, Inc.

SOURCE PDL BioPharma, Inc.



RELATED LINKS
[ http://www.pdl.com ]

Publication Contributing Sources